Axcelis Technologies, Inc. Profile Avatar - Palmy Investing

Axcelis Technologies, Inc.

Axcelis Technologies, Inc. designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia. The company offers high energy, high current, and medium…
Semiconductors
US, Beverly [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 28% Weak
Profitability n.A. n.A.
Fin. Growth 67% Positive
Leverage & Liquidity 17% Weak
Per Share Metrics 33% Weak
Fin. Health n.A. n.A.
Fundamentals

Valuation

Metric Q4 Q1 Δ in %
EV/EBITDA 18.61 59.83 50.44
Graham Fair Price -12.80 31.35 35.95
PEG -65.13 -0.65 1.87
Price/Book -17.06 4.07 4.90
Price/Cash Flow 18.04 90.34 76.54
Prices/Earnings 19.09 17.77 14.92
Price/Sales 6.32 14.53 13.67
Price/FCF 18.04 90.34 76.54
Naive Interpretation member
01 - Valuation · Weak
Fundamentals

Profitability

Metric Q4 Q1 Δ in %
Gross Profit Margin 3.47 0.46 0.44
Operating Margin -12.06 0.22 0.25
ROA -28.76 0.04 0.06
ROE 0.08 0.06 -30.36
ROIC 0.07 0.05 -25.99
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q4 Q1 Δ in %
Debt QOQ -0.02 0.67 -97.14
Dividends QOQ 0.00 0.00 0.00
EBIT QOQ 0.10 -0.28 176.94
EPS QOQ 0.08 -0.27 241.56
FCF QOQ 1.96 -0.27 -86.36
Revenue QOQ 0.06 -0.19 203.77
Naive Interpretation member
03 - Financial Growth · Positive
Fundamentals

Leverage & Liquidity

Metric Q4 Q1 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 160.00 206.10 28.81
Days Sales Outstanding (DSO) 63.22 74.37 17.64
Inventory Turnover 0.56 0.44 -22.36
Debt/Capitalization 0.05 0.05 -5.12
Quick Ratio 2.54 2.67 5.18
Naive Interpretation member
04 - Leverage & Liquidity · Weak
Fundamentals

Per Share Metrics

Metric Q4 Q1 Δ in %
Book Value 26.44 27.63 4.49
Cash 15.47 16.24 4.97
Capex -0.31 -0.05 84.01
Free Cash Flow 1.69 1.24 -26.58
Revenue 9.49 7.73 -18.49
Naive Interpretation member
05 - Per Share Metrics · Weak
Fundamentals

Financial Health

Metric Q4 Q1 Δ in %
Current Ratio 3.79 4.00 5.53
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -1.11 -0.99 11.17
Naive Interpretation Member
06 - Financial Health · Bad
End of ACLS's Analysis
CIK: 1113232 CUSIP: 054540208 ISIN: US0545402085 LEI: - UEI: -
Secondary Listings
ACLS has no secondary listings inside our databases.